ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979

In Brief: House Money Bill Reportedly Will Not Increase

September 18, 1981

Six More CCOPS In Funding Range For Recompetition

February 9, 1990

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

February 25, 2005